Cost Effectiveness Analysis of an Ancillary Study of the REMOTEV Study

University Hospital, Strasbourg, France

Status: Unknown

Conditions: Venous Thromboembolic Disease

Study type: Observational

Funder types: Other

Identifiers

NCT03887806

7158 (Other Identifier)

Details and patient eligibility

About

The implications of the medico-economic impact are essential in the choice of first-line therapists. The economic impact is an important criterion to recommend the privileged use of Direct Oral Anticoagulants (AOD) in first intention.

Enrollment: 300 estimated patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion and exclusion criteria

Inclusion criteria

• Major patient whose age is ≥18 years
• Patient with a diagnosis of MTEV: pulmonary embolism or deep vein thrombosis diagnosed by the diagnostic reference methods according to the recommendations
• Major patient included in the REMOTEV registry
• Patient having accepted that his data recorded in the REMOTEV register be re-used for research and publication purposes

Criteria of non-inclusion

• Refusal to participate in the REMOTEV register
• Patient who refused to have his data reused for research and publication purposes
• Pregnant woman
• Subjects under safeguard of justice Subject under guardianship or curatorship